Small Molecules

How to mitigate the risks involved in highly potent APIs.

Exploring the potential of leriglitazone in helping patients with cerebral X-linked adrenoleukodystrophy.

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

Voting is now open for our 2025 Company of the Year Awards.

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

The material composition of consumables – whether plastic or glass – impacts their carbon footprints. But which is more efficient?

Research and development in sleep-wake disorders has been asleep on its feet

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

The latest X-ray technology goes beyond foreign body detection, ensuring each dose is right first time – every time.

Why the traditional model of drug development is no longer fit for purpose.